Abstract
Background and Aim
Patients with lung cancer experience high rates of psychosocial distress. They are also more likely to have unresolved, unmet social needs which may contribute to psychosocial distress. Despite this, neighborhood‐level social determinants of health (SDOH) in relation to psychosocial distress have not been adequately investigated in patients with lung cancer. The goal of this study is to examine the association between neighborhood‐level SDOH and psychosocial distress among a sample of newly diagnosed patients with lung cancer.
Methods
This cross‐sectional study included newly diagnosed, adult lung cancer patients from an accredited cancer center. Psychosocial distress was measured with the Distress Thermometer. Neighborhood‐level SDOH indicators for income and education were used to create a composite SDOH variable categorized into low, medium, and high deprivation levels. Covariates were age, gender, race/ethnicity, comorbidity index, cancer stage, and insurance status. Using multivariate logistic regression modeling, the association of psychosocial distress with the neighborhood‐level SDOH was examined.
Results
The prevalence of psychosocial distress in the sample was 58.4%. Neighborhood‐level SDOH indicators were not significantly associated with psychosocial distress. Higher odds of psychosocial distress were significantly associated with being female and having distant or regional cancer versus localized cancer. The age group 66–75 years was significantly associated with lower distress compared with those aged <65 years.
Conclusions
Psychosocial distress was consistently high across all the SDOH deprivation categories; but these neighborhood‐level SDOH indicators do not appear to be predictive of psychosocial distress at the time of diagnosis of lung cancer.
Keywords: lung cancer, psychosocial distress, social determinants of health
1. INTRODUCTION
Lung cancer is the second most frequently diagnosed cancer and the leading cause of cancer death worldwide. 1 , 2 In 2020, there were an estimated 2.2 million new cases and 1.8 million deaths from lung cancer globally. 1 The American Cancer Society estimated that there would be approximately 235 760 new cases and 131 880 deaths of lung cancer in the US in 2021. 2
Psychosocial distress as defined in the National Comprehensive Cancer Network (NCCN) clinical guidelines is “a multifactorial, unpleasant experience of a psychological (i.e., cognitive, behavioral, emotional), social, spiritual, and/or physical nature, that may interfere with the ability to cope effectively with cancer, its physical symptoms and its treatment”. 3 Psychosocial distress is a widely recognized occurrence among patients with cancer. 4 In response, the American College of Surgeons' Commission on Cancer enacted accreditation standards that require cancer centers to implement the five steps of comprehensive psychosocial distress screening, as a means to ensure that patients with distress are promptly identified and treated. 5 The five steps include: screening to identify distress, evaluation to determine the cause of the distress, appropriate referral pathways initiated with follow‐up, and documentation with regular auditing for quality improvement. 6
In comparison with other cancer populations, lung cancer patients have one of the highest rates of psychosocial distress, with reported rates ranging between 43.5% to 61.6%. 7 , 8 , 9 , 10 Factors that can contribute to this are poorer prognosis and increased burden of symptoms of the cancer 11 , 12 as well as stigma and self‐blame because of the causal impact of prolonged tobacco use. 11 , 13 , 14 Consequences of psychosocial distress in cancer patients include difficulty in making treatment decisions with resulting delay in care, disease progression, negative health outcomes, reduced quality of life, and poorer prognosis. 15 , 16 , 17 It is therefore important to identify which particular lung cancer patient groups are at high risk for psychosocial distress.
In various studies, several factors were found to be associated with higher levels of psychosocial distress 10 , 18 , 19 : younger age, female gender, current cigarette smoking, advanced stage of disease, receiving surgery or chemotherapy and a higher ECOG scale of performance status score. These studies were however limited to the examination of demographic and clinical factors. Examining social determinants of health (SDOH) in healthcare research is important because they influence health care outcomes and associated disparities in care delivery. 20 , 21 SDOH are “the conditions in the environments where people are born, live, learn, work, play, worship, and age that affect a wide range of health, functioning, and quality‐of‐life outcomes and risks”. 22 The SDOH of a community often are rooted in its overall socioeconomic status (SES), as those with lower SES tend to live in areas with poor SDOH. SES indicators are considered in defining SDOH. 23 SDOH associated with lower SES have been linked with greater unmet health needs (physical and social), poorer health outcomes, health inequities and psychosocial distress. 20 , 21 , 24 , 25 Low SES and psychosocial distress are often independently associated with poorer health outcomes. 3 , 26 , 27 Studies examining the relationship between SES and psychological distress have reported a synergistic effect of worsened health outcomes in distressed patients with low SES. 28 , 29 High levels of psychological distress were most common among individuals with lower levels of SES and social capital, even after adjusting for participant demographic characteristics and life events. 30 These studies were, however, conducted in non‐cancer populations. Despite the high prevalence of psychosocial distress 7 , 8 , 9 , 10 and high proportion of unmet social needs 31 , 32 in patients diagnosed with lung cancer and the correlation of these factors with SDOH, to the best of our knowledge, no study has investigated the association of SDOH and psychosocial distress in patients with lung cancer.
Therefore, the goal of this study was to assess the association between neighborhood‐level SDOH and psychosocial distress among newly diagnosed lung cancer patients. We hypothesized that newly diagnosed patients with lung cancer who experienced greater neighborhood‐level SDOH disadvantage (i.e., who live in a more socioeconomically deprived neighborhood) would experience higher levels of psychosocial distress. The formulation of this hypothesis was guided by elements of the Commission on Social Determinants of Health (CSDH) conceptual framework. This framework posits that indicators of socioeconomic position such as income and education operate through a set of intermediary determinants of health including neighborhood quality and psychosocial stressors, to shape health outcomes.
2. MATERIALS AND METHODS
2.1. Study design & setting
This study utilized a cross‐sectional study design with patient data from the UMass Memorial Health Care (UMMHC) System. UMMHC is the largest health care system in Central and Western Massachusetts. The Cancer Center in UMMHC is accredited by the American College of Surgeons Commission on Cancer (CoC).
2.2. Study sample
All newly diagnosed adult lung cancer patients seen within UMMHC between 2017 and 2021, and who completed a psychosocial distress screening were included in this study. A total of 1516 patients were newly diagnosed with lung cancer and of these, 1115 had no recorded data on psychosocial distress scores, thus they were excluded. This resulted in an analytic sample size of 401.
2.3. Data sources
Data were obtained from the University of Massachusetts Chan Medical School (UMMS) Research Informatics Core. UMMS is the academic partner of UMMHC. The Research Informatics Core provides access to and supports the use of multiple and complex data sources. For this study, the data sources included (1) Electronic Medical Records which were the data source for the sociodemographic, clinical and psychosocial distress data, and (2) Census data from the 2010 5‐year ACS survey. 33 Participants' addresses were geocoded to obtain corresponding census tract information, which provides neighborhood‐level indices of SDOH. A manual chart review and data abstraction of the electronic medical records captured in EPIC were also conducted to obtain missing data and to clarify ambiguous data.
2.4. Ethical approval
Approval for the study and waiver of consent were received from the UMMS Committee for the Protection of Human Subjects in Research.
3. MEASURES
3.1. Psychosocial distress
The psychosocial distress data are obtained from the participants using the Distress Thermometer (DT) and its associated problem list. 34 In UMMHC, the DT is completed by patients at the time of the first in‐person visit following a cancer diagnosis. The DT is a validated, single‐item patient‐reported visual scale developed by the National Comprehensive Cancer Network (NCCN). 34 It has a range of 0–10, with 0 indicating no distress and 10 indicating extreme distress. Patients are asked to circle the number that best describes how much distress they have experienced over the past week. A suggested cut‐off value for the DT to identify distress by the NCCN is 4. 34 , 35 Studies have been done to describe the translation and validation of the DT in cancer patients across different cultures and countries. In the majority of examined studies, a cut point of 4 to indicate significant level of distress, maximized sensitivity and specificity, when compared to a well‐established benchmark such as the Hospital Anxiety and Depression Scale (HADS). 36 , 37 , 38 , 39 , 40 In this study, we therefore categorized patients reporting a distress level of 4 or greater as distressed, and those reporting a distress level less than 4 as non‐distressed.
3.2. Neighborhood‐level social determinants of health
Neighborhood‐level SDOH data were obtained by geocoding the participants' address at time of diagnosis, to obtain census tract‐level information. We chose standard economic indicators with known associations with health outcomes. 41 , 42 , 43 These indicators and operational definitions are neighborhood income (aggregated from census tract median household income), and neighborhood education (aggregated from the census tract percent of high school graduates). Each indicator's sample mean value was used as a cutoff and we grouped patients with a value equal to or greater than the mean as living in a neighborhood with SDOH with low deprivation level and those reporting a value less than the mean as living in a neighborhood with high deprivation level SDOH.
To address multicollinearity of these indicators, 44 a composite SDOH variable was created by summing the two individual indicators. Each indicator had a score of 0 if low deprived SDOH or 1 if high deprived SDOH. Therefore, the composite SDOH variable had a score range of 0 to 2 and a higher score meant greater SDOH deprivation. This variable was labeled as low, medium, and high neighborhood‐level SDOH deprivation levels (Figure 1), allowing us to compare individuals with higher level of neighborhood‐level SDOH deprivation to those with lower levels.
FIGURE 1.

Composite SDOH variable
3.3. Covariates
A priori choice of covariates was made based on factors found in the literature to be associated with psychosocial distress in lung cancer patients. 10 , 18 , 19 Sociodemographic and clinical information collected were age at diagnosis (≤65, 66–75, >75), gender, race/ethnicity (Hispanic/Latino, Non‐Hispanic White, Non‐Hispanic Others), cancer stage at diagnosis (stage I/localized, stage II & III/regional, stage IV/distant), insurance (Medicare/MassHealth/Private) and comorbidity disease count (0, 1, ≥2). We carefully curated a list of comorbid conditions that are often highly prevalent in lung cancer and are known to have impactful interaction with lung cancer. 45 , 46 For the comorbidity count for each patient, we counted the number of these conditions that were present in the electronic health records using ICD‐10 codes. 47 The selected comorbid conditions included myocardial infarction, hypertension, congestive heart failure, peripheral vascular disease, cerebrovascular disease, COPD, diabetes, renal disease, liver disease, and rheumatologic disease.
4. STATISTICAL ANALYSIS
Descriptive analysis (counts and proportions) was calculated overall and by distress levels to describe the characteristics of all variables. Pearson's chi‐square tests were used to evaluate the bivariate relationship between the psychosocial distress outcome and the demographic, clinical, and neighborhood‐level SDOH variables. p value < .05 was considered significant. Logistic regression models were used to predict the associations of clinically significant distress, defined as a psychosocial distress score of ≥4. We first calculated the unadjusted odds ratios and 95% Confidence Interval (CI), then a fully adjusted model controlling for the sociodemographic and clinical variables. All statistical analyses were performed using Stata 17.0 statistical software (StataCorp, College Station, TX).
5. RESULTS
5.1. Sample description
Approximately one‐third of the 401 study participants were aged ≤65 years (33.9%), and 52% were female. Most participants (91%) were non‐Hispanic White. One‐quarter (25%) had localized (stage I) cancer. More than 80% of participants had at least one comorbid condition. All participants had a form of insurance and the majority (82%) had public insurance.
The mean neighborhood‐level SDOH indicator values were $65 000 for median household income, and 88% for percentage of high school graduates. With respect to the neighborhood‐level SDOH composite variable, almost half (48.7%) of the participants were classified in the low deprivation category. (Table 1).
TABLE 1.
Prevalence of psychosocial distress by sample characteristics
| Total | No psychosocial distress (Score < 4) b | Psychosocial distress (Score ≥ 4) b | p Value | ||||
|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | ||
| Overall | 401 | 100 | 167 | 41.6 | 234 | 58.4 | |
| Gender | <.001 | ||||||
| Female | 208 | 51.9 | 58 | 27.9 | 150 | 72.1 | |
| Male | 193 | 48.1 | 109 | 56.5 | 84 | 43.5 | |
| Age (years) | .033 | ||||||
| ≤65 | 136 | 33.9 | 46 | 33.8 | 90 | 66.2 | |
| 66–75 | 142 | 35.4 | 70 | 49.3 | 72 | 50.7 | |
| ≥76 | 123 | 30.7 | 51 | 41.5 | 72 | 58.5 | |
| Race/Ethnicity a | .618 | ||||||
| Hispanic/Latino | 17 | 4.3 | 9 | 52.9 | 8 | 47.1 | |
| Non‐Hispanic white | 363 | 91.2 | 150 | 41.3 | 213 | 58.7 | |
| Non‐Hispanic other | 18 | 4.5 | 7 | 38.9 | 11 | 61.1 | |
| Stage at diagnosis | .008 | ||||||
| Localized | 101 | 25.2 | 54 | 53.5 | 47 | 46.5 | |
| Regional | 157 | 39.2 | 65 | 41.4 | 92 | 58.6 | |
| Distant | 143 | 35.7 | 48 | 33.6 | 95 | 66.4 | |
| Comorbid disease score | .917 | ||||||
| 0 | 71 | 17.7 | 28 | 39.4 | 43 | 60.6 | |
| 1 | 114 | 28.4 | 48 | 42.1 | 66 | 57.9 | |
| ≥2 | 216 | 53.9 | 91 | 42.1 | 125 | 57.9 | |
| Health insurance a | .137 | ||||||
| Medicare | 275 | 68.8 | 123 | 44.7 | 152 | 55.3 | |
| Mass health | 53 | 13.2 | 17 | 32.1 | 36 | 67.9 | |
| Private | 72 | 18.0 | 26 | 36.1 | 46 | 63.9 | |
| SDOH composite variable a (Deprivation level) | |||||||
| Low | 151 | 48.7 | 63 | 41.7 | 88 | 58.3 | .388 |
| Medium | 48 | 15.5 | 16 | 33.3 | 32 | 66.7 | |
| High | 111 | 35.8 | 50 | 45.0 | 61 | 55.0 | |
Missing data on ethnicity (n = 3), health insurance (n = 1), SDOH (n = 91).
Distress scores range from 1–10.
5.2. Prevalence of psychosocial distress
Of the 401 participants included in the study sample, 234 (58.4%) had distress score of ≥4. The prevalence of distress was significantly higher in participants who were female (72.1%), those younger than 66 years (66.2%), and those with distant (stage IV) cancer (66.4%) (Table 1).
5.3. Logistic regression analysis
The neighborhood‐level SDOH composite variable was not significantly associated with psychosocial distress even after fully adjusting for other a priori‐defined covariates (ORmedium = 1.27, 95% CI = 0.60; 2.69), (ORhigh = 0.78, 95% CI = 0.44; 1.39; Table 2). Using a fully adjusted model, female participants had a 3.97 times higher likelihood of psychosocial distress compared to male patients (OR = 3.97, 95% CI = 2.39; 6.60). Participants aged 66–75 years had 57% lower likelihood of psychosocial distress compared with those aged below 65 years (OR = 0.43, 95% CI = 0.19; 0.95). Having regional or distant stage cancer was significantly associated with higher risk of psychological distress, compared to those with localized (stage I) cancer (ORreg = 1.91, 95% CI = 1.01; 3.62), (ORdistant = 2.56, 95% CI = 1.31; 5.01) (Table 2).
TABLE 2.
Unadjusted and fully adjusted odds ratios (ORs) of psychosocial distress by participants' characteristics
| Unadjusted OR (95%CI) | Adjusted OR (95%CI) a | |
|---|---|---|
| Gender | ||
| Male | Ref | Ref |
| Female | 3.36 (2.21–5.09) | 3.97 (2.39–6.60) |
| Age (years) | ||
| ≤65 | Ref | Ref |
| 66–75 | 0.53 (0.32–0.85) | 0.43 (0.19–0.95) |
| ≥76 | 0.72 (0.44–1.20) | 0.55 (0.23–1.30) |
| Race/Ethnicity | ||
| Non‐Hispanic white | Ref | Ref |
| Non‐Hispanic other | 1.11 (0.42–2.92) | 0.80 (0.26–2.46) |
| Hispanic/Latino | 0.63 (0.24–1.66) | 0.32 (0.09–1.12) |
| Stage at diagnosis | ||
| Localized | Ref | Ref |
| Regional | 1.63 (0.98–2.69) | 1.91 (1.01–3.62) |
| Distant | 2.27 (1.35–3.84) | 2.56 (1.31–5.01) |
| Comorbid disease score | ||
| 0 | Ref | Ref |
| 1 | 0.90 (0.49–1.64) | 1.16 (0.52–2.57) |
| ≥2 | 0.89 (0.52–1.55) | 0.94 (0.44–1.97) |
| Health insurance | ||
| Medicare | Ref | Ref |
| MassHealth | 1.71 (0.92–3.20) | 1.0 (0.38–2.63) |
| Private | 1.43 (0.84–2.45) | 0.69 (0.29–1.66) |
| SDOH composite variable (Deprivation level) | ||
| Low | Ref | Ref |
| Medium | 1.43 (0.72–2.83) | 1.27 (0.60–2.69) |
| High | 0.87 (0.53–1.43) | 0.78 (0.44–1.39) |
Model fully adjusted for all listed variables.
6. DISCUSSION
The study was to our best knowledge the first to examine the relationship between neighborhood‐level SDOH and psychosocial distress in newly diagnosed lung cancer patients. Our study findings, both in the univariate and multivariate analyses, showed no association between neighborhood‐level SDOH and psychosocial distress levels. This result was inconsistent with our initial hypothesis. We expected that those participants with SDOH reflective of high deprivation levels would also have an increased probability of suffering from distress at the time of lung cancer diagnosis. Instead, we found a high proportion of clinically meaningful psychosocial distress across all SDOH deprivation levels, suggesting that the diagnosis of lung cancer may generate distress irrespective of the patient's neighborhood socioeconomic circumstances. This overall high proportion of patients with elevated psychosocial distress in the study sample (58.4%) is consistent with previous studies in lung cancer patients. 7 , 8 , 9 , 10 While cancer centers are required to implement psychosocial screening for accreditation, 5 optimal timing of screening and referral practices remain challenges. The trajectory of psychosocial distress after initial diagnosis remains unknown, as do population subgroup differences. In this study, psychosocial distress was ascertained only one time, at the first visit to the cancer center following diagnosis, which is the procedure of UMMHC. Therefore, we were unable to assess if the high level of psychosocial distress observed in this sample persisted throughout the course of treatment nor could we assess the association of neighborhood‐level SDOH with psychosocial distress levels across different time points in the cancer care continuum.
An important observation was the high proportion of newly diagnosed lung cancer patients who did not have documented psychosocial distress scores. Only about 26% had documented distress‐screening scores. There did not appear to be differences in the characteristics of those who had documented distress scores and those who did not. Like the study sample, most of the patients without distress scores were non‐Hispanic White (89%), 52% were female and majority had public insurance. This lack of documentation may preclude adequate monitoring, evaluation, and follow‐up of distressed patients.
We observed differences in psychosocial distress by gender, age group, and cancer stage. Being female and having regional/distant disease compared to localized disease were significantly associated with higher likelihood of being distressed. In comparison with those aged 65 years or younger, participants aged 66 to 75 years were less likely to report psychosocial distress. These results are consistent with the literature on factors associated with psychosocial distress among lung cancer patients. 18 , 19 Our findings reinforce the need for lung cancer care centers to provide resources to meet the psychosocial needs of patients.
The strengths of this study include its innovation as the first to evaluate the association of SDOH and psychosocial distress in lung cancer patients. Other innovations that strengthen this study are the creation of a SDOH composite variable for better analysis and a comorbid disease score comprising a carefully curated list of comorbid conditions prevalent in lung cancer patients to reduce potential confounding. Composite variables help reduce the incidence of Type I error and multicollinearity for regression analysis. 44
6.1. Study limitations
An important limitation was that only about 26% of the newly diagnosed patients with lung cancer had documented distress‐screening scores, thus reducing the sample size. The cross‐sectional study design precludes assessment of causation. Another limitation is assessment of SDOH and psychosocial distress at only one time, which precludes assessing if the absence of an association is consistent across different time points in the cancer continuum. Also, in this study, out of the five key domains of SDOH–economic stability, education access and quality, health care access and quality, neighborhood and built environment, social and community context, 48 we could only access measures for economic stability and education. Lastly, participants were from only one cancer care center, which limits generalizability. However, the median values observed on the three SDOH indicators were very similar to national averages, indicating that our sample is somewhat reflective of the US population.
6.2. Clinical implication
Findings from this study emphasize the importance of comprehensive psychosocial distress screening which includes the prompt identification, management, and proper documentation of psychosocial distress, in all lung cancer patients regardless of any other patient characteristics. Ensuring that all patients are screened irrespective of their SODH deprivation level will likely improve equitable whole‐person care.
7. CONCLUSION
Psychosocial distress was consistently high overall and with no variation by neighborhood‐level SDOH deprivation levels, in this sample of patients newly diagnosed with lung cancer. This suggests that the diagnosis of lung cancer may by itself; generate psychosocial distress irrespective of the patient's neighborhood socioeconomic circumstances. Therefore, ensuring that comprehensive psychosocial distress screening is implemented for all lung cancer patients is critical. Future research exploring the association of SDOH with psychosocial distress post‐diagnosis may be warranted because SDOH which strongly influence health related behaviors and are known drivers of disparities in healthcare, 49 may have a significant association with psychosocial distress at different time points across the lung cancer care continuum.
AUTHOR CONTRIBUTIONS
Oluwabunmi M. Emidio: Conceptualization (lead); data curation (lead); formal analysis (lead); investigation (lead); methodology (lead); project administration (lead); writing – original draft (lead); writing – review and editing (lead). Christine Frisard: Data curation (supporting); formal analysis (supporting); software (supporting). Sarah L. Cutrona: Conceptualization (supporting); methodology (supporting); resources (supporting); writing – review and editing (supporting). Kathleen M. Mazor: Conceptualization (supporting); methodology (supporting); supervision (supporting); writing – review and editing (supporting). Sharina D. Person: Conceptualization (supporting); data curation (supporting); formal analysis (supporting); methodology (supporting); writing – review and editing (supporting). Stephenie C. Lemon: Conceptualization (equal); data curation (supporting); methodology (equal); resources (lead); supervision (lead); writing – review and editing (lead).
ETHICAL STATEMENT
Approval for the study and waiver of consent were received from the UMMS Committee for the Protection of Human Subjects in Research.
FUNDING INFORMATION
The Prevention and Control of Cancer: Training in Implementation Science (PRACCTIS) Program (National Cancer Institute Grant # T32 CA172009).
CONFLICT OF INTEREST
The authors declare no conflicts of interest.
ACKNOWLEDGEMENTS
The authors would like to acknowledge the support of the UMASS Chan Medical School Research Informatics Core in data abstraction.
Emidio OM, Cutrona SL, Person SD, Mazor KM, Frisard C, Lemon SC. Association of neighborhood‐level social determinants of health with psychosocial distress in patients newly diagnosed with lung cancer. Cancer Reports. 2022;5(11):e1734. doi: 10.1002/cnr2.1734
Funding information National Cancer Institute, Grant/Award Number: T32 CA172009
Contributor Information
Oluwabunmi M. Emidio, Email: bunmiemidio@gmail.com, Email: oluwabunmi.emidio@umassmed.edu.
Stephenie C. Lemon, Email: stephenie.lemon@umassmed.edu.
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available from the corresponding author upon reasonable request.
REFERENCES
- 1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209‐249. [DOI] [PubMed] [Google Scholar]
- 2. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7‐33. [DOI] [PubMed] [Google Scholar]
- 3. Riba MB, Donovan KA, Andersen B, et al. Distress management, version 3.2019, NCCN clinical practice guidelines. Oncology. 2019;17(10):1229. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Gorman L. The psychosocial impact of cancer on the individual, family, and society. Psychosocial Nursing Care along the Cancer Continuum. Oncology Nursing Society; 1998:3‐25. [Google Scholar]
- 5. Cancer ACoSCo . Cancer Program Standards: Ensuring Patient‐Centered Care. 2016. 2019. [Google Scholar]
- 6. Lazenby M, Tan H, Pasacreta N, Ercolano E, McCorkle R. The five steps of comprehensive psychosocial distress screening. Curr Oncol Rep. 2015;17(5):447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Badger T, Lebaron VT, Mccorkle R. Screening for emotional distress in older patients with lung cancer. Lung Cancer. 2010;24(4). [Google Scholar]
- 8. Carlson LE, Zelinski EL, Toivonen KI, et al. Prevalence of psychosocial distress in cancer patients across 55 north American cancer centers. J Psychosoc Oncol. 2019;37(1):5‐21. [DOI] [PubMed] [Google Scholar]
- 9. Zabora J, Brintzenhofeszoc K, Jacobsen P, et al. A new psychosocial screening instrument for use with cancer patients. Psychosomatics. 2001;42(3):241‐246. [DOI] [PubMed] [Google Scholar]
- 10. Graves KD, Arnold SM, Love CL, Kirsh KL, Moore PG, Passik SD. Distress screening in a multidisciplinary lung cancer clinic: prevalence and predictors of clinically significant distress. Lung Cancer (Amsterdam, Netherlands). 2007;55(2):215‐224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Lehto RH. Psychosocial challenges for patients with advanced lung cancer: interventions to improve well‐being. Lung Cancer (Auckl). 2017;8:79‐90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Ferrell B, Sun V, Hurria A, et al. Interdisciplinary palliative Care for Patients with Lung Cancer. J Pain Symptom Manage. 2015;50(6):758‐767. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Carolyn Messner D, LCSW‐R B. Lung Cancers, and Stigma: Perception or Reality?.
- 14. Chapple A, Ziebland S, McPherson A. Stigma, shame, and blame experienced by patients with lung cancer: qualitative study. BMJ. 2004;328(7454):1470. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Vodermaier A, Lucas S, Linden W, Olson R. Anxiety after diagnosis predicts lung cancer‐specific and overall survival in patients with stage III non‐small cell lung cancer: a population‐based cohort study. J Pain Symptom Manage. 2017;53(6):1057‐1065. [DOI] [PubMed] [Google Scholar]
- 16. Barrera I, Spiegel D. Review of psychotherapeutic interventions on depression in cancer patients and their impact on disease progression. Int Rev Psychiatry. 2014;26(1):31‐43. [DOI] [PubMed] [Google Scholar]
- 17. Holland JC, Andersen B, Breitbart WS, et al. Distress management: clinical practice guidelines in oncology™. JNCCN J Natl Compr Cancer Netw. 2007;5(1):66‐98. [PubMed] [Google Scholar]
- 18. Morrison EJ, Novotny PJ, Sloan JA, et al. Emotional problems, quality of life, and symptom burden in patients with lung cancer. Clin Lung Cancer. 2017;18(5):497‐503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Leung B, Laskin J, Wu J, Bates A, Ho C. Assessing the psychosocial needs of newly diagnosed patients with nonsmall cell lung cancer: identifying factors associated with distress. Psychooncology. 2019;28(4):815‐821. [DOI] [PubMed] [Google Scholar]
- 20. Heiman HJ, Artiga S. Beyond Health Care: the Role of Social Determinants in Promoting Health and Health Equity. KFF.org; 2015. [Google Scholar]
- 21. Solar O, Irwin A. A Conceptual Framework for Action on the Social Determinants of Health. WHO Document Production Services; 2010. [Google Scholar]
- 22. Healthy People 2030 USDoHaHS, Office of Disease Prevention and Health Promotion . Retrieved September 15 2021, from https://health.gov/healthypeople/objectives-and-data/social-determinants-health.
- 23. Prevention OoD, Promotion H. Healthy People 2020: Social determinants of health. Retrieved September 2020;5:2019.
- 24. Alegría M, NeMoyer A, Falgàs Bagué I, Wang Y, Alvarez K. Social determinants of mental health: where we are and where we need to go. Curr Psychiatry Rep 2018;20(11):95‐, 20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Cole MB, Nguyen KH. Unmet social needs among low‐income adults in the United States: associations with health care access and quality. Health Serv Res. 2020;55(S2):873‐882. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Flaskerud JH, DeLilly CR. Social determinants of health status. Issues Ment Health Nurs. 2012;33(7):494‐497. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Taghizadeh A, Pourali L, Vaziri Z, Saedi HR, Behdani F, Amel R. Psychological distress in cancer patients. Middle East J Cancer. 2018;9(2):143‐149. [Google Scholar]
- 28. Lazzarino AI, Hamer M, Stamatakis E, Steptoe A. The combined association of psychological distress and socioeconomic status with all‐cause mortality: a national cohort study. JAMA Intern Med. 2013;173(1):22‐27. [DOI] [PubMed] [Google Scholar]
- 29. Pond E, Fowler K, Hesson J. The influence of socioeconomic status on psychological distress in Canadian adults with ADD/ADHD. J Atten Disord. 2019;23(9):940‐948. [DOI] [PubMed] [Google Scholar]
- 30. Myer L, Stein DJ, Grimsrud A, Seedat S, Williams DR. Social determinants of psychological distress in a nationally‐representative sample of south African adults. Soc Sci Med. 2008;66(8):1828‐1840. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Giuliani M. MS17.01 unmet needs and QOL of lung cancer survivors. J Thorac Oncol. 2018;13(10):S276‐S277. [Google Scholar]
- 32. Giuliani M, Milne R, Puts M, et al. The prevalence and nature of supportive care needs in lung cancer patients. Curr Oncol. 2016;23(4):258‐265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Herman E. The American community survey: an introduction to the basics. Gov Inf Q. 2008;25(3):504‐519. [Google Scholar]
- 34. Holland JC, Andersen B, Breitbart WS, et al. Distress management. J Natl Compr Cancer Netw. 2013;11(2):190‐209. [DOI] [PubMed] [Google Scholar]
- 35. Network NCC . NCCN Clinical Practice Guidelines in Oncology. Distress management. Version 1.2017. Fort Washington, PA. 2017.
- 36. Ozalp E, Cankurtaran ES, Soygür H, Geyik PO, Jacobsen PB. Screening for psychological distress in Turkish cancer patients. Psychooncology. 2007;16(4):304‐311. [DOI] [PubMed] [Google Scholar]
- 37. Shim EJ, Shin YW, Jeon HJ, Hahm BJ. Distress and its correlates in Korean cancer patients: pilot use of the distress thermometer and the problem list. Psychooncology. 2008;17(6):548‐555. [DOI] [PubMed] [Google Scholar]
- 38. Tuinman MA, Gazendam‐Donofrio SM, Hoekstra‐Weebers JE. Screening and referral for psychosocial distress in oncologic practice: use of the distress thermometer. Cancer. 2008;113(4):870‐878. [DOI] [PubMed] [Google Scholar]
- 39. Donovan KA, Grassi L, McGinty HL, Jacobsen PB. Validation of the distress thermometer worldwide: state of the science. Psychooncology. 2014;23(3):241‐250. [DOI] [PubMed] [Google Scholar]
- 40. Jacobsen PB, Donovan KA, Trask PC, et al. Screening for psychologic distress in ambulatory cancer patients: a multicenter evaluation of the distress thermometer. Cancer. 2005;103(7):1494‐1502. [DOI] [PubMed] [Google Scholar]
- 41. Chetty R, Stepner M, Abraham S, et al. The association between income and life expectancy in the United States, 2001–2014. JAMA. 2016;315(16):1750‐1766. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Krueger PM, Tran MK, Hummer RA, Chang VW. Mortality attributable to low levels of education in the United States. PLoS One. 2015;10(7):e0131809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Freeman AK. Racial residential segregation and the distribution of health‐related organizations in urban neighborhoods. Soc Probl. 2017;64(2):256‐276. [Google Scholar]
- 44. Song M‐K, Lin F‐C, Ward SE, Fine JP. Composite variables: when and how. Nurs Res. 2013;62(1):45‐49. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Dutkowska A, Antczak A. Comorbidities in lung cancer. Advances in Respiratory Medicine. 2016;84(3):186‐192. [DOI] [PubMed] [Google Scholar]
- 46. Sigel K, Wisnivesky JP. Comorbidity profiles of patients with lung cancer: a new approach to risk stratification? Ann Am Thorac Soc. 2017;14(10):1512‐1513. [DOI] [PubMed] [Google Scholar]
- 47. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol. 2003;56(3):221‐229. [DOI] [PubMed] [Google Scholar]
- 48. People H. Social determinants of health. Washington, DC: US Department of Health and Human Services, Office of Disease Prevention, and Health Promotion https://www.healthypeople.gov/2020/topicsobjectives/topic/social-determinants-of-health Accessed May. 2020; 30:2017.
- 49. Braveman P, Gottlieb L. The social determinants of health: it's time to consider the causes of the causes. Public Health Rep. 2014;129(2):19‐31. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
